Isaac J. Rondon

Isaac J. Rondon has extensive work experience in the biotechnology and pharmaceutical industry. Isaac J. is currently serving as the Vice President at EpiBiologics. Prior to that, they held roles at Gritstone Oncology as the Vice President of Antibody Discovery and as the Head of Protein Sciences.

Isaac also has a strong background in research and development at Pfizer, where they worked for several years. Isaac J. served as a Senior Director, overseeing the discovery and development of biologics for the CTI-San Francisco portfolio. Isaac J. also held the position of Director at the Pfizer Center for Therapeutic Innovation (CTI) San Francisco, where they established a new team and directed activities related to biologic discovery and development.

Before joining Pfizer, Isaac worked at XOMA as the Director of Genetic Engineering, where they founded the Department of Genetic Engineering and developed novel protein display platforms. Isaac J. also served as the Associate Director of Genetic Engineering and Senior Scientist II of Antibody Discovery and Engineering, leading teams in the construction and evaluation of antibody libraries.

Isaac's early career includes roles at Catalyst Biosciences and Kalobios Inc, where they contributed to the strengthening of technology platforms and the selection of novel proteases and antibodies. Isaac J. also worked at Dyax as an Associate Director, overseeing Discovery Research and collaborating with key opinion leaders.

Overall, Isaac J. Rondon has a wealth of experience in biologics discovery and development, as well as expertise in genetic engineering and the construction of antibody libraries.

Isaac J. Rondon's education history includes a variety of academic pursuits. Isaac J. completed their Bachelor of Science degree in Biochemistry at Louisiana State University. Following this, they pursued their Ph.D. in Pharmacology at Tulane University School of Medicine. Isaac later attended Harvard Medical School as a Fellow, focusing on Antibody engineering, HIV, and Gene therapy. Additionally, they studied Business Administration and Management, General at ITIS "Enrico Mattei." Specific years for each educational experience are not provided.